Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction...
HypogonadismErectile DysfunctionThe objective of the study is to assess and compare the preliminary efficacy, safety and tolerability of fispemifene 300 mg and placebo given once daily for 8 weeks in the treatment of hypogonadal men with erectile dysfunction (ED) unresponsive to PDE5 inhibitors.
A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia
Erectile DysfunctionBenign Prostatic HyperplasiaStudy LVHR is a Phase 3 study which will examine the efficacy and safety of tadalafil 2.5 and 5 mg once daily versus placebo for the treatment of erectile dysfunction (ED) and signs and symptoms of benign prostatic hyperplasia (BPH) in men with both ED and signs and symptoms of BPH.
Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction...
Erectile DysfunctionThe purpose of this study is to investigate the effect of up to 200 mg of PF-00446687 on erectile activity in males suffering from erectile dysfunction as well as examining the safety and toleration of the drug.
Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1...
Erectile DysfunctionAsses efficacy of Vardenafil in patients with type 1 diabetes and erectile dysfunction
A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile...
Erectile DysfunctionThe primary objective of this study is to assess the efficacy together with safety of a flexible regimen, for a period of twelve weeks, of three doses (5 mg, 10mg and 20mg) of Bay 38-9456, a phosphodiesterase type V inhibitor, in males with erectile dysfunction treated with sildenafil in the previous <6 months .At entry, once the Inclusion and Exclusion criteria are confirmed, the study medication will be administered for twelve weeks in an open label design. Vardenafil will be administered, as needed, at a fix dose of 10 mg once daily for the first four weeks of treatment. At the Investigators' discretion, on the basis of efficacy and safety evaluations, the patients may, then, receive the same dose strength of their assigned study medication or, at the subsequent clinic visit(s), the next lower dose (5 mg vardenafil) or the next higher dose (20 mg vardenafil) for the subsequent four weeks of treatment. Previous dose level of vardenafil is either maintained, increased or decreased by one step according to the three applicable dose strengths (5 mg, 10 mg, 20 mg ). The highest dosage of vardenafil (20 mg) per day will not be exceeded. After twelve weeks of treatment, the patient will be contacted twenty four hours following the last visit in order to collect data concerning serious adverse events.
Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction
Erectile DysfunctionTo find out more information on how effective and safe vardenafil is at treating impotence in men living in Russia.
BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction
Erectile DysfunctionPurpose of the study is:- To assess the efficacy and tolerability of vardenafil in male subjects suffering from erectile dysfunction as compared to placebo- To assess the influence of vardenafil on the self-esteem and self-confidence of subjects suffering from erectile dysfunction following treatment with vardenafil as compared to placebo
A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to...
Erectile DysfunctionThis purpose of the study was to evaluate the earliest time to onset of action in adults with erectile dysfunction (often called impotence). In this study vardenafil has been compared to placebo. Patients were asked to fill in questionnaires and a diary in which they filled in details about attempts at sexual activity during study period. Patients received also a stopwatch to record the time of onset of erection. Stopwatch should be started immediately prior to initiating sexual activity and stopped when an erection perceived to be adequate for penetration was obtained.
A Double-blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile...
Erectile DysfunctionTo find out more information on how treating impotence with vardenafil in comparison to placebo affects the quality of life (QoL) of men and their partners. Subjects will receive 10mg vardenafil or placebo for 4 weeks followed by an 8 week period when the dose of vardenafil may be reduced to 5mg or increased to 20mg. Subjects will then receive their 'preferred' dose for 14 weeks. During this time Quality of Life Measures will be collected via questionnaires
Assess Efficacy in Subjects With Traumatic Spinal Cord Injury
Erectile DysfunctionSpinal Cord InjuryAssess efficacy of Vardenafil in patients with traumatic spinal cord injury